v3.26.1
Revenue (Tables)
3 Months Ended
Mar. 29, 2026
Revenue from Contract with Customer [Abstract]  
Disaggregation of Revenue
The following table summarizes Total revenues by business unit:
Three Months Ended
(In millions)March 29, 2026
March 30, 2025 (1)
Labs$353.1 $373.0 
Immunohematology (2)
138.3 128.5 
Donor Screening (2)
7.8 12.8 
Point of Care112.8 170.9 
Molecular Diagnostics7.8 7.6 
Total revenues$619.8 $692.8 
(1) Certain reclassifications have been made to prior period amounts to conform to the current period presentation.
(2) As a result of the wind-down of the U.S. donor screening portfolio, the Transfusion Medicine business unit is shown in its two product categories: Immunohematology and Donor Screening.